29 June 2025
Understand the significance of Ozempic and Mounjaro in the evolving landscape of diabetes care and weight management in South Africa.
19 March 2025
Pharmaceutical companies urge the Trump administration and EU to exclude medical goods from tariff wars, warning of potential price hikes and access barriers.
4 March 2025
The Competition Commission is investigating insulin manufacturers Novo Nordisk and Sanofi Aventis, raising concerns about accessibility to diabetes care.
8 November 2024
ObesityWeek 2024 attracted unprecedented attention from Wall Street, highlighting obesity treatment's booming pharmaceutical industry.
4 November 2024
New Zealand customs has seized semaglutide-based drugs made in Bangladesh, underscoring a rise in global demand for cheaper alternatives to Ozempic.
28 October 2024
Healthcare costs for US obesity patients rise with GLP-1 drugs despite their weight-loss benefits.
24 October 2024
Novo Nordisk's share price dropped 19% amidst growing competition from Eli Lilly in the diabetes and weight-loss drug market.